CASP10
CASP10 (caspase 10, also known as MCH4 and FLICE-2) is a member of the cysteine-aspartic acid protease family that acts in the execution phase of apoptosis. It cleaves and activates caspases 3 and 7, and is itself processed by caspase 8. Browse Assay Genie's current range of CASP10 research reagents below, or read on for the biology behind the target.
CASP10 is a cysteine protease belonging to the caspase family, which has a central role in the execution phase of apoptosis. Caspases are made as inactive proenzymes. Proteolytic processing at conserved aspartic acid residues produces a large and a small subunit, and these dimerise to form the active enzyme. Within this sequential activation cascade, the CASP10 protein cleaves and activates caspases 3 and 7, while CASP10 itself is processed by caspase 8.
The CASP10 gene encodes caspase-10, which belongs to the peptidase C14A family and is classified as EC 3.4.22.63. HGNC places it in the groups of caspases, death effector domain containing proteins and death inducing signalling complex components. Alternatively spliced transcript variants encode different isoforms; UniProt notes that isoform C is proteolytically inactive, so the isoform under study matters when interpreting activity.
The protein was previously named caspase 10, apoptosis-related cysteine protease (or peptidase), and is also known as MCH4 and FLICE-2. Mutations in the CASP10 gene are associated with type IIA autoimmune lymphoproliferative syndrome, non-Hodgkin lymphoma and gastric cancer, which makes it a point of interest for studies of dysregulated cell death and immune homeostasis. Researchers often study it alongside other caspases, such as the initiator caspase 8 and the executioner caspases 3 and 7.
CASP10 sits in the sequential caspase cascade that drives the execution phase of apoptosis, cleaving and activating caspases 3 and 7.
As a proenzyme processed by caspase 8 at conserved aspartic residues, CASP10 is a useful model for proteolytic activation and subunit assembly.
Mutations in CASP10 are associated with type IIA autoimmune lymphoproliferative syndrome, linking the protease to immune cell regulation.
CASP10 mutations are associated with non-Hodgkin lymphoma and gastric cancer, so the gene is studied in tumour cell death pathways.
CASP10 is a cysteine-aspartic acid protease that contributes to the execution phase of apoptosis. Once processed, it cleaves and activates caspases 3 and 7. The CASP10 protein is itself processed by caspase 8, placing it within a sequential caspase activation cascade.
CASP10 is also called caspase 10, MCH4 and FLICE-2, and was formerly named caspase 10, apoptosis-related cysteine protease. Alternatively spliced transcript variants encode different isoforms. UniProt notes that isoform C is proteolytically inactive, unlike the active enzyme forms.
Yes. According to the NCBI Gene summary, mutations in the CASP10 gene are associated with type IIA autoimmune lymphoproliferative syndrome, non-Hodgkin lymphoma and gastric cancer. Check the datasheet of any product for its validated reactivity before planning cross-species work.
Other caspases, including the executioner caspases CASP10 activates and the caspase 8 that processes it, with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt Q92851; product specifications from Assay Genie datasheets.